Oncotelic Therapeutics, Inc. (OTLC)
OTCMKTS · Delayed Price · Currency is USD
0.0475
-0.0025 (-5.00%)
At close: Jun 4, 2026
Oncotelic Therapeutics Market Cap
Oncotelic Therapeutics has a market cap or net worth of $21.07 million as of June 4, 2026. Its market cap has decreased by -9.33% in one year.
Market Cap
21.07M
Enterprise Value
34.24M
Revenue
n/a
Ranking
n/a
PE Ratio
0.08
Stock Price
$0.05
Market Cap Chart
Since April 23, 2019, Oncotelic Therapeutics's market cap has increased from 9.14M to 21.07M, an increase of 130.39%. That is a compound annual growth rate of 12.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 22.17M | -40.28% |
| Dec 31, 2025 | 37.13M | 160.46% |
| Dec 31, 2024 | 14.26M | -6.64% |
| Dec 29, 2023 | 15.27M | -13.24% |
| Dec 30, 2022 | 17.60M | -71.94% |
| Dec 31, 2021 | 62.72M | 225.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 26.06M |
| EOM Pharmaceuticals Holdings | 25.28M |
| Arch Biopartners | 23.80M |
| LianBio | 17.84M |
| Galera Therapeutics | 16.20M |
| Anebulo Pharmaceuticals | 15.30M |
| ZIVO Bioscience | 14.87M |
| Zeo ScientifiX | 14.70M |